Gut microbiota imbalance promotes the onset of colorectal cancer

The gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti – holder of the Microbiology…

Omega-3 shows protection against heart disease-related death, without prostate cancer risk

Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why…

The ways astronauts prep for spaceflight could benefit cancer patients, say researchers

During spaceflight, astronauts experience similar physical stress as cancer patients undergoing treatments such as chemotherapy, immunotherapy, and targeted therapy. In a commentary published November 14 in the journal Cell , researchers suggest that by mimicking a NASA astronaut’s schedule of…

FEFU scientists obtained new compounds with potential antitumor effect from sea sponge

Chemists from Far Eastern Federal University’s School of Natural Sciences (SNS FEFU) developed a new method to synthesize biologically active derivatives of fascaplysin — cytotoxic pigment of a sea sponge. For the first time, they got a sufficient amount of…

Blocking a survival mechanism could tackle melanoma treatment resistance

The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a study published in Nature Communications today.* Researchers from the…

How Crohn’s disease-associated bacteria tolerate antibiotics

Bacteria associated with Crohn’s disease rely on multiple stress responses to survive, multiply, and tolerate antibiotics within white blood cells called macrophages, according to a study published November 14 in the open-access journal PLOS Pathogens by Olivier Espéli of the…

The ways astronauts prep for spaceflight could benefit cancer patients, say researchers

During spaceflight, astronauts experience similar physical stress as cancer patients undergoing treatments such as chemotherapy, immunotherapy, and targeted therapy. In a commentary published November 14 in the journal Cell , researchers suggest that by mimicking a NASA astronaut’s schedule of…

FEFU scientists obtained new compounds with potential antitumor effect from sea sponge

Chemists from Far Eastern Federal University’s School of Natural Sciences (SNS FEFU) developed a new method to synthesize biologically active derivatives of fascaplysin — cytotoxic pigment of a sea sponge. For the first time, they got a sufficient amount of…

How Crohn’s disease-associated bacteria tolerate antibiotics

Bacteria associated with Crohn’s disease rely on multiple stress responses to survive, multiply, and tolerate antibiotics within white blood cells called macrophages, according to a study published November 14 in the open-access journal PLOS Pathogens by Olivier Espéli of the…

Blocking a survival mechanism could tackle melanoma treatment resistance

The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a study published in Nature Communications today.* Researchers from the…

Twenty-seven life scientists become EMBO Young Investigators

Heidelberg, 13 November 2019 – EMBO congratulates twenty-seven life scientists on their selection as new EMBO Young Investigators. They join a network of 129 current and 340 former Young Investigators, and will begin their four-year programme tenure in January 2020.…

Complementary therapies can do more harm than good when breast cancer becomes visible

Lisbon, Portugal: Patients with advanced breast cancer that has spread to the skin are likely to cause more harm than good if they use complementary therapies to treat their skin lesions. Professor Maria João Cardoso, head breast surgeon at the…

Twenty-seven life scientists become EMBO Young Investigators

Heidelberg, 13 November 2019 – EMBO congratulates twenty-seven life scientists on their selection as new EMBO Young Investigators. They join a network of 129 current and 340 former Young Investigators, and will begin their four-year programme tenure in January 2020.…